Hyperthyroidism medications

24,409views

Hyperthyroidism medications

C4 (SA)

C4 (SA)

Renal system anatomy and physiology
Endocrine system anatomy and physiology
Glomerular filtration
Measuring renal plasma flow and renal blood flow
Regulation of renal blood flow
Renal clearance
Proximal convoluted tubule
Loop of Henle
Distal convoluted tubule
Tubular reabsorption and secretion
Tubular secretion of PAH
Tubular reabsorption of glucose
Urea recycling
Tubular reabsorption and secretion of weak acids and bases
Renin-angiotensin-aldosterone system
Diabetes mellitus
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Diabetes insipidus
Insulin
Glucagon
Antidiuretic hormone
Movement of water between body compartments
Body fluid compartments
Sodium homeostasis
Diabetes mellitus: Clinical
Diabetes mellitus: Pathology review
Endocrine system: Diabetes mellitus
Hyponatremia
Hyponatremia: Clinical
Hypernatremia: Clinical
Hypernatremia
Diabetes insipidus and SIADH: Pathology review
Diabetic retinopathy
Gestational diabetes
Managing diabetes during the holidays: Information for patients and families
Insulins
Atherosclerosis and arteriosclerosis: Pathology review
Diabetic nephropathy
Diabetic ketoacidosis (DKA): Nursing process (ADPIE)
Hypertension: Clinical
Hypertension
Hypertensive emergency
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Miscellaneous lipid-lowering medications
Hypercholesterolemia: Clinical
Dyslipidemias: Pathology review
Hypertriglyceridemia
Familial hypercholesterolemia
Osmotic diuretics
Hypokalemia
Hypokalemia: Clinical
Hyperkalemia
Hyperkalemia: Clinical
Loop diuretics
Potassium sparing diuretics
Thiazide and thiazide-like diuretics
Hypoglycemics: Insulin secretagogues
Miscellaneous hypoglycemics
ACE inhibitors, ARBs and direct renin inhibitors
Carbonic anhydrase inhibitors
Thyroid nodules and thyroid cancer: Pathology review
Thyroid nodules and thyroid cancer: Clinical
Thyroid cancer
Hashimoto thyroiditis
Thyroid storm
Thyroid hormones
Hypothyroidism and thyroiditis: Clinical
Riedel thyroiditis
Postpartum thyroiditis
Anatomy of the thyroid and parathyroid glands
Hyperthyroidism: Clinical
Euthyroid sick syndrome
Hyperthyroidism: Pathology review
Hypothyroidism: Pathology review
Calcitonin
Vitamin D
Parathyroid hormone
Hyperthyroidism
Graves disease
Toxic multinodular goiter
Hyperparathyroidism
Hypoparathyroidism
Hypercalcemia
Hypocalcemia
Parathyroid disorders and calcium imbalance: Pathology review
Hyperthyroidism medications
Hypothyroidism medications
Osteogenesis imperfecta
Acute kidney injury: Clinical
Acute tubular necrosis
Kidney stones: Clinical
Kidney stones
The role of the kidney in acid-base balance
Acid-base disturbances: Pathology review
Metabolic acidosis
Renal tubular acidosis
Respiratory acidosis
Renal tubular acidosis: Pathology review
Metabolic and respiratory acidosis: Clinical
Potassium homeostasis
Plasma anion gap
Respiratory alkalosis
Metabolic alkalosis
Hydronephrosis
Renal artery stenosis
Kidney stones: Pathology review
Subacute granulomatous thyroiditis
Chronic kidney disease
Chronic kidney disease: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Pituitary tumors: Pathology review
Hypoprolactinemia
Pituitary adenoma
Multiple endocrine neoplasia
Prolactinoma
Hypopituitarism: Clinical
Hypopituitarism: Pathology review
Growth hormone deficiency
Growth hormone and somatostatin
Acromegaly
Hyperphosphatemia
Hypophosphatemia
Minimal change disease
Membranous nephropathy
Rapidly progressive glomerulonephritis
Acute pyelonephritis
Chronic pyelonephritis
Polycystic kidney disease
Medullary cystic kidney disease
Medullary sponge kidney
Multicystic dysplastic kidney
Renal cell carcinoma
Urinary incontinence
Neurogenic bladder
Lower urinary tract infection
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Electrolyte disturbances: Pathology review
Renal failure: Pathology review
Nephritic syndromes: Pathology review
Nephrotic syndromes: Pathology review
Urinary incontinence: Pathology review
Renal and urinary tract masses: Pathology review
Urinary tract infections: Pathology review
Adrenocorticotropic hormone
Oxytocin and prolactin
Somatostatin
Synthesis of adrenocortical hormones
Cortisol
Testosterone
Estrogen and progesterone
Phosphate, calcium and magnesium homeostasis
Congenital adrenal hyperplasia
Primary adrenal insufficiency
Waterhouse-Friderichsen syndrome
Hyperaldosteronism
Adrenal cortical carcinoma
Cushing syndrome
Conn syndrome
Thyroglossal duct cyst
Thyroid eye disease (NORD)
Hypothyroidism
Hyperpituitarism
Hyperprolactinemia
Gigantism
Hypopituitarism
Pituitary apoplexy
Sheehan syndrome
Constitutional growth delay
Precocious puberty
Delayed puberty
Premature ovarian failure
Polycystic ovary syndrome
Androgen insensitivity syndrome
Kallmann syndrome
5-alpha-reductase deficiency
Pheochromocytoma
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Multiple endocrine neoplasia: Pathology review
Adrenal hormone synthesis inhibitors
Mineralocorticoids and mineralocorticoid antagonists
Menstrual cycle
Amenorrhea
Androgens and antiandrogens
Virilization: Clinical
Cushing syndrome: Clinical
Congenital adrenal hyperplasia: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
Parathyroid conditions and calcium imbalance: Clinical
MEN syndromes: Clinical
Glucocorticoids
Nephritic and nephrotic syndromes: Clinical
Metabolic and respiratory alkalosis: Clinical
Amenorrhea: Clinical
Abnormal uterine bleeding: Clinical
Puberty and Tanner staging

Transcript

Watch video only

In hyperthyroidism, ‘hyper’ refers to having too much, and ‘thyroid’ refers to thyroid hormones, so hyperthyroidism refers to a condition where there’s excess thyroid hormones.

Medications used to treat hyperthyroidism either reduce the level of thyroid hormones or treat the symptoms by targeting the affected tissue.

There are 2 different thyroid hormones; triiodothyronine or T3, and thyroxine or T4.

Now, if we zoom into the thyroid gland, we’ll find thousands of follicles, which are small, hollow spheres whose walls are lined with follicular cells, or thyrocytes.

Zooming further into these follicular cells, we’ll see their apical side that surrounds a central lumen filled with a viscous fluid called the colloid.

The colloid contains the precursor hormone thyroglobulin.

The basolateral side of follicular cells is in contact with blood vessels that supply these cells.

Synthesis of thyroid hormones begins when follicular cells take in inorganic iodide ions from the blood, along with two sodium ions, via a sodium- iodide symporter.

This step is known as ‘iodide trap’.

The iodide ion is pumped via the pendrin protein, into the viscous fluid inside the follicle called the colloid, which contains thyroglobulin; the precursor of thyroid hormone.

In the colloid, inorganic iodide undergoes oxidation via the enzyme thyroid peroxidase or TPO, to become organic iodide, which then binds to the tyrosine in thyroglobulin.

This step is known as iodination.

Some tyrosine residues bind to only one iodine and form monoiodotyrosine or MIT, whereas others bind to two iodine atoms to form diiodotyrosine or DIT.

These molecules are then coupled together by the same enzyme thyroid peroxidase.

This process is known as coupling.

Coupling one MIT with one DIT creates T3, while coupling 2 DIT molecules creates T4.

T4 is generally created in greater amounts than T3, with T3 being the more active form with a half life of 1 to 2 days, while T4 is less active but has a longer half life of 6 to 8 days.

Once released from the thyroid gland, most of the T3 and T4 travels via the blood by binding with the thyroxine - binding globulin, or TBG, to reach the target cell.

Alternatively, small amounts of T3 and T4 stay unbound, and therefore they are referred to as “free” thyroid hormones.

Only “free” thyroid hormones are physiologically active because they are able to enter the cell.

Now, once inside the cell, T4 is mostly converted into T3 by the enzyme 5’- deiodinase. T3 binds to thyroid hormone receptors which are within the cell’s nucleus, and these receptors regulate gene expression, which ultimately lead to various metabolic and physiologic effects in the body.

This increase in metabolism uses up sugars and fats for energy and produces more body heat.

Thyroid hormones also help activate the sympathetic nervous system which is responsible for the fight or flight response.

This increases heart rate and cardiac output, respiratory rate, and mental alertness.

Thyroid hormones also increase the gastrointestinal or GI motility and they are necessary for normal neuronal development in growing fetuses and young children.

Now, hyperthyroidism can happen in a few different ways.

The most common cause is Graves’ disease, an autoimmune disorder where B cells produce autoantibodies against thyroid stimulating hormone receptors on follicular cells.

These autoantibodies bind to the receptors and activate them, which causes the thyroid follicles to grow and produce more thyroid hormones.

One complication is Graves’ ophthalmopathy which is inflammation and edema in the tissue around the eyes, causing the eyeball to be displaced forwards, eyelids to retract and giving the eyes a “bulgingappearance.

Other disorders like toxic multinodular goiter and thyroiditis can also cause increased release of thyroid hormones.

Now, the symptoms of hyperthyroidism include weight loss despite an increase in appetite because of the higher basal metabolic rate; heat intolerance because the body is producing more heat; and rapid heart rate or tachycardia, sweating, hyperactivity, anxiety and insomnia because of the effect of thyroid hormones on the sympathetic nervous system.

Untreated hyperthyroidism combined with a stressor like an infection or illness can trigger a life- threatening complication called thyroid storm.

Many of the symptoms of hyperthyroidism then become exaggerated, leading to severe tachyarrhythmia, high fever, delirium, and coma.

Now, there are several classes of medications to control hyperthyroidism.

First, we can target the thyroid gland itself, and either decrease the synthesis of thyroid hormones or prevent them from being released.

The other option, at the target tissue peripherally; is to decrease the effectiveness of the thyroid hormones; this only manages the symptoms but doesn’t treat the cause.

Let’s start with the radioactive iodine therapy, also known as “radioiodine ablation therapy”.

The isotope of iodine that is used is I131 .

It’s taken peroral and eventually gets taken up by the thyroid.

Over the course of a few weeks, the radioactive isotope collects in the colloid and emits beta radiation that causes permanent damage to the thyroid.

This is the definitive treatment for hyperthyroidism caused by Graves’ disease and toxic multinodular goiter, but it could also worsen Graves’ ophthalmopathy.

Since the thyroid is permanently destroyed, the person will need to take thyroid hormone replacements like levothyroxine to prevent hypothyroidism.

Radioactive iodine crosses the placenta and is secreted in breast milk, so it should be avoided in people who are pregnant or breastfeeding.

Therefore, administration of radioactive iodine to childbearing individuals requires a negative pregnancy test!

Finally, as far as side effects go, radioactive iodide can cause infertility, thyroiditis, and radiation toxicity, such as neoplasia, hematopoietic suppression, and salivary and lacrimal toxicity.

Next, we have thioamides, which include propylthiouracil, or PTU, and methIMAzole.

Both of these medications are given perorally and are absorbed by the thyroid where they inhibit thyroid peroxidase.

This stops the oxidation of iodide ions into organic iodine, the iodination of tyrosine residues in thyroglobulin, and the coupling of MIT and DIT to form T3 and T4.

It’s important to note that these medications do not inhibit the release of thyroid hormones; therefore they require several weeks until the thyroid depletes its storage of hormones to manifest their therapeutic effect.

In addition, PTU also works in the peripheral tissue by inhibiting 5’- deiodinase to block the conversion of T4 into T3, which makes it the preferred medication during thyroid storms.

Key Takeaways

Hyperthyroidism refers to a condition in which there is excess thyroid hormones. Medications used to treat hyperthyroidism aim at reducing the level of thyroid hormones or the management of associated symptoms. Hyperthyroidism medications include beta blockers, radioactive iodine, propylthiouracil, methimazole, Lugol's iodine, propranolol, and corticosteroids.

Sources

  1. "Katzung & Trevor's Pharmacology Examination and Board Review,12th Edition" McGraw-Hill Education / Medical (2018)
  2. "Rang and Dale's Pharmacology" Elsevier (2019)
  3. "Goodman and Gilman's The Pharmacological Basis of Therapeutics, 13th Edition" McGraw-Hill Education / Medical (2017)
  4. "Hyperthyroidism: Diagnosis and Treatment" Am Fam Physician (2016)
  5. "Subclinical Hyperthyroidism: When to Consider Treatment" Am Fam Physician (2017)
  6. "Hyperthyroidism" The Lancet (2016)
  7. "THE EFFECT OFD- VERSUSL- PROPRANOLOL IN THE TREATMENT OF HYPERTHYROIDISM" Clinical Endocrinology (1990)
  8. "Increased cancer incidence after radioiodine treatment for hyperthyroidism" Cancer (2007)
  9. "Lugol’s solution and other iodide preparations: perspectives and research directions in Graves’ disease" Endocrine (2017)